Table 2.
aHR | 95% CI | P values* | |
High Ang-2 | 1.88 | 1.23 to 2.88 | 0.003 |
High CSF-1 | 0.879 | 0.330 to 2.34 | 0.797 |
HighAng-2/CSF-1 | 1.61 | 1.06 to 2.42 | 0.026 |
*P value, aOR and 95% CI using Cox regression analysis, adjusted by tumour stage, age, gender, histological type and smoking status.
aHR, adjusted Harzard Ratio; Ang-2, angiopoietin-2; CSF-1, colony stimulating factor-1; NSCLC, non-small cell lung cancer.